Elmore Patent Law Group, P.C.
Hepatitis B antiviral agents
The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV life cycle of the hepatitis B virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HBV infection. The invention also relates to methods of treating an HBV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. 
Enanta Pharmaceuticals, Inc.
A A C A
A61K A61K C07D A61K
inventional inventional inventional inventional
Hui Yao-Ling Byung-Chul Jorden Xiaowen Wei Xuri Yat Sun
Cao Qiu Suh Kass Peng Li Gao Or